congenital imperforate hymen with hydrocolpos and

6
UNCORRECTED PROOF Case Report Congenital Imperforate Hymen with Hydrocolpos and Hydronephrosis associated with Severe Hydramnios and Increase of Maternal Ovarian Steroidogenic Enzymes Emmanouil Karteris 1 , Helen Foster 1 , Maria Karamouti 2 , and Anastasia Goumenou 1,2 Q2 1 Centre for Cell Chromosome Biology, Biosciences, School of Health Sciences and Social Care, Brunel University, Uxbridge, UK; 2 University of Crete, Division of Medicine, Department of Obstetrics and Gynecology, Heraklion, Crete, Greece Abstract. Study Objective: To study a clinical features of patient presented with severe hydramnios, associated with hydronephrosis, that was antenatally diagnosed and has been successfully treated immediately after birth. At a mo- lecular level, we investigated the gene expression of key steroidogenic enzymes from the maternal ovary. Design: Ultrasound scan, MRI, semi-quantitative RT-PCR Setting: The patient was admitted to the University Hos- pital, University of Crete, Medical School, Greece, where all clinical data has been obtained. Gene expression studies took place at Biosciences, Brunel University, UK. Results: Semi-quantitative RT-PCR analyses revealed that there is upregulation of key steroidogenic genes in the maternal ovary, including steroidogenic acute regula- tory protein, and the cytochrome P450 heme-containing proteins CYP11A, CYP17 and CYP19. From a clinical per- spective, the prenatal ultrasound scan and MRI findings showed a multicystic pelvic mass, bilateral hydronephrosis and prior to delivery severe polyhydramnios. Conclusion: This clinical case is the only one that we have found in the current literature where congenital imper- forate hymen accompanied with hematocolpos is associated with renal obstruction in combination with polyhydramnios and increase in maternal steroidogenic enzymes. Key Words. Ovarian steroidogenic enzymes—Hyd rocolpos—Polyhydramnios Introduction Congenital imperforate hymen is the most frequent congenital malformation of the female genital track, where mucus and blood from endometrial sloughing accumulate in the vagina. 1 When presented in adults, there is a distension of the vaginal canal that can lead to cervical dilation and formation of a hematometra and hematosalpinx. Symptoms in adults include cy- clic and abdominal pain, amenorrhea, and difficulty with urination. 2 Retrograde menstruation, i.e., back- ward menstruation into the peritoneal cavity, can lead to the onset of endometriosis. Endometriosis is a clinical and pathological entity that is characterized by the presence of tissue that re- sembles functioning endometrial glands and stroma outside the uterine cavity. Symptoms include infertil- ity and chronic pelvic pain. 3 It has been hypothesized that vaginal secretions accumulate in response to cir- culating maternal estrogens. 4 Interestingly, recent clinical and laboratory studies support the concept that endometriosis is an estrogen-dependent condi- tion. Indeed, high estradiol concentrations have been identified as a requisite for proliferation of endometri- otic lesions, and inducement of a hypoestrogenic state is a current therapeutic approach. 5 To the best of our knowledge, hydrocolpos (cystic dilatation of the vagina) as an isolated prenatal finding has only been reported twice previously. 6,7 Vaginal obstruction may be characterized by the sole presence of an imperforate hymen, a transverse vaginal septum, or by the presence of a urogenital sinus or cloacal malformation. 8 Imperforate hymen is the result of the failure of canalization of the vaginal plate, 1 which is formed in part of the Mu ¨llerian ducts and from the urogenital sinus. 8 A rare condition of congenital im- perforate hymen has been presented in which obstruc- tion of the vagina was associated with accumulation of uterovaginal secretions produced under circulating maternal estrogen stimulation, and the development of a hydrometrocolpos. Large hematocolpos may lead Address correspondence to: Emmanouil Karteris, PhD, Centre for Cell Chromosome Biology, Biosciences, School of Health Sci- ences and Social Care, Brunel University, Uxbridge, UB8 3PH, UK; E-mail: [email protected] Ó 2009 North American Society for Pediatric and Adolescent Gynecology Published by Elsevier Inc. 1083-3188/09/$36.00 doi:10.1016/j.jpag.2009.10.002 J Pediatr Adolesc Gynecol (2009) -:- ARTICLE IN PRESS 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 PEDADO1098_proof ĸ 09–11–2009 23:14:21

Upload: dangdiep

Post on 18-Jan-2017

236 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Congenital Imperforate Hymen with Hydrocolpos and

Q2

J Pediatr Adolesc Gynecol (2009) -:-

ARTICLE IN PRESS

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

Case Report 74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

OOF

Congenital Imperforate Hymen with Hydrocolpos andHydronephrosis associated with Severe Hydramnios andIncrease of Maternal Ovarian Steroidogenic Enzymes

Emmanouil Karteris1, Helen Foster1, Maria Karamouti2, and Anastasia Goumenou1,2

1Centre for Cell Chromosome Biology, Biosciences, School of Health Sciences and Social Care, Brunel University, Uxbridge, UK;2University of Crete, Division of Medicine, Department of Obstetrics and Gynecology, Heraklion, Crete, Greece

C90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

RRE

Abstract. Study Objective: To study a clinical features ofpatient presented with severe hydramnios, associated withhydronephrosis, that was antenatally diagnosed and hasbeen successfully treated immediately after birth. At a mo-lecular level, we investigated the gene expression of keysteroidogenic enzymes from the maternal ovary.

Design: Ultrasound scan, MRI, semi-quantitative RT-PCRSetting: The patient was admitted to the University Hos-

pital, University of Crete, Medical School, Greece, whereall clinical data has been obtained. Gene expression studiestook place at Biosciences, Brunel University, UK.

Results: Semi-quantitative RT-PCR analyses revealedthat there is upregulation of key steroidogenic genes inthe maternal ovary, including steroidogenic acute regula-tory protein, and the cytochrome P450 heme-containingproteins CYP11A, CYP17 and CYP19. From a clinical per-spective, the prenatal ultrasound scan and MRI findingsshowed a multicystic pelvic mass, bilateral hydronephrosisand prior to delivery severe polyhydramnios.

Conclusion: This clinical case is the only one that wehave found in the current literature where congenital imper-forate hymen accompanied with hematocolpos is associatedwith renal obstruction in combination with polyhydramniosand increase in maternal steroidogenic enzymes.

O 116

117

118

119

120

121

122

NCKey Words. Ovarian steroidogenic enzymes—Hyd

rocolpos—Polyhydramnios

123

124

125

126

127

128

129

UIntroduction

Congenital imperforate hymen is the most frequentcongenital malformation of the female genital track,

Address correspondence to: Emmanouil Karteris, PhD, Centre for

Cell Chromosome Biology, Biosciences, School of Health Sci-ences and Social Care, Brunel University, Uxbridge, UB8 3PH,

UK; E-mail: [email protected]

� 2009 North American Society for Pediatric and Adolescent GynecologyPublished by Elsevier Inc.

130

131

132

133

PEDADO1098_proof �

TEDPRwhere mucus and blood from endometrial sloughing

accumulate in the vagina.1 When presented in adults,there is a distension of the vaginal canal that can leadto cervical dilation and formation of a hematometraand hematosalpinx. Symptoms in adults include cy-clic and abdominal pain, amenorrhea, and difficultywith urination.2 Retrograde menstruation, i.e., back-ward menstruation into the peritoneal cavity, can leadto the onset of endometriosis.

Endometriosis is a clinical and pathological entitythat is characterized by the presence of tissue that re-sembles functioning endometrial glands and stromaoutside the uterine cavity. Symptoms include infertil-ity and chronic pelvic pain.3 It has been hypothesizedthat vaginal secretions accumulate in response to cir-culating maternal estrogens.4 Interestingly, recentclinical and laboratory studies support the conceptthat endometriosis is an estrogen-dependent condi-tion. Indeed, high estradiol concentrations have beenidentified as a requisite for proliferation of endometri-otic lesions, and inducement of a hypoestrogenic stateis a current therapeutic approach.5

To the best of our knowledge, hydrocolpos (cysticdilatation of the vagina) as an isolated prenatal findinghas only been reported twice previously.6,7 Vaginalobstruction may be characterized by the sole presenceof an imperforate hymen, a transverse vaginal septum,or by the presence of a urogenital sinus or cloacalmalformation.8 Imperforate hymen is the result ofthe failure of canalization of the vaginal plate,1 whichis formed in part of the Mullerian ducts and from theurogenital sinus.8 A rare condition of congenital im-perforate hymen has been presented in which obstruc-tion of the vagina was associated with accumulationof uterovaginal secretions produced under circulatingmaternal estrogen stimulation, and the developmentof a hydrometrocolpos. Large hematocolpos may lead

1083-3188/09/$36.00doi:10.1016/j.jpag.2009.10.002

134

09–11–2009 23:14:21

Page 2: Congenital Imperforate Hymen with Hydrocolpos and

C

2 Karteris et al: Congenital Imperforate Hymen

ARTICLE IN PRESS

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

UNCORRE

to secondary oligoamniosis, due to renal obstructionand deteriorating renal function. Interestingly, anadult case of hematocolpos was a consequence ofradiotherapy for cervix carcinoma.9 Moreover, in a re-cent study of a 15-year-old girl with imperforatehymen with hematocolpometra, the serum tumormarker CA125 was elevated.10

This particular clinical case is the only that we havefound in the current literature in which congenitalimperforate hymen accompanied with hydrocolpos isassociated with renal obstruction in combination withpolyhydramnios and increase in key steroidogeniccomponents of the maternal ovary.

Methods

Ovarian SamplesThe sample used in this clinical case was obtainedduring cesarean section surgery, due to the presenceof a cyst. Therefore, apart from the cyst, an ovarianbiopsy was also obtained from surface to clarify thenature of the cyst. The ovarian biopsy was taken withscissors and there was no significant bleeding. Allcontrol women were age matched, undergoing cesar-ean section, and there was a presence of ovarian cysts.For this study, maternal informed consent was ob-tained after the procedure was fully explained. Allprocedures followed were in accordance with the eth-ical standards of the responsible institutional commit-tee on human experimentation. Ovarian samples(n 5 4; 1 from the clinical case and 3 pooled controls)were placed in RNAlater� (Sigma Aldrich, UK) untilfurther use.

RNA Isolation and cDNA SynthesisEach sample was lysed in 600 ml of RNA lysis bufferusing the TissueLyser (Qiagen, UK). Total RNA wasextracted from these specimens using an RNA extrac-tion kit (Sigma, UK), according to manufacturer’s in-structions. RNA concentration was determined byspectrophotometric analysis (NanoDrop, Thermo Sci-entific, UK). RNA (200ng) was reverse-transcribed intocDNA using 5 IU/ml RNase H reverse transcriptase(Invitrogen, UK).

Semiquantitative RT-PCRPCR amplification was carried out using Taq poly-merase (Invitrogen). The primers used for thisstudy were: steroidogenic acute regulatory protein(StAR, 181 bp): 5’-CGTGACTTTGTGAGCG-3’ and5’-GCCACGTAAGTTTGGT-3’; CYP11A (202 bp):5’-AGAGTTGAAATCCAACA CC-3’ and 5’-TGGGACAGACGACTGA-3’; CYP17 (205 bp): 5’-GTGACCGTAA CCGTCT-3’ and 5’- ATGAACTGATCCGGCT-3’; HSD3B2 (298 bp): 5’-CCATACCCGTA-CAGCA-3’and 5’-AT TGACCTCGGACACT-3’;

PEDADO1098_pr

TEDPROOF

CYP19 (242 bp) 5’-CAGAGGCCAAGAGTTTGAGG-3’ and 5’-ACACTAGCAGGTGGGTTTGG-3’;b-actin (216 bp): 5’-AAGAGAGGCATCCTCACCCT-3’ and 5’-TACATGGCTGG GGTGTTGAA-3’.After an initial denaturation step of 94�C for 4 min,28 cycles were performed consisting of an initial de-naturing step at 94�C for 30s, followed by extensionat 60�C for 30 s and elongation at 72�C for 1 min.Densitometric analysis of resulted PCR products re-solved on a 2% agarose gel were quantified usingthe AlphaEase FC software.

Results

Molecular Findings—Changes in the GeneExpression of Steroidogenic Components in theMaternal OvaryAs mentioned previously, it has been hypothesizedthat vaginal secretions accumulate in response to cir-culating maternal estrogens.4 In this study we alsosought to investigate this hypothesis by assessingthe gene expression of key steroidogenic enzymesfrom the maternal ovary compared to age-matchedpooled controls. Semi-quantitative RT-PCR revealedsignificant upregulation of the following genes whencompared to an age-matched normal ovary: StARby 1.55, CYP11A by 1.67, CYP17 by 7.1 andCYP19 by 5.2 fold (Fig 1). The most profound in-crease was that of CYP17 and CYP19 when comparedto the normal ovary, whereas the levels of 3bHSD2 re-mained unaltered (data not shown). This is the firststudy that we have found to describe a fetus withhydrocolpos exhibiting changes in the expression ofmaternal steroidogenic enzymes at the ovarian level.

Clinical Findings—Identification of Cystic Massand Hydronephrosis Using Ultrasound Scan andSurgical ProceduresAn abdominal cystic mass with maximum diameter43.5� 29.4 mm was discovered on a prenatal sono-gram in a female fetus at 29 weeks gestation ina 32-year-old woman para 1, gravida 3. Fetal biome-try was within the normal range for gestational age.The patient’s prenatal course, which included amnio-paracentesis (because of patient’s family history fortrisomy 21 in a maternal aunt) had been uncompli-cated and previous ultrasound scan examinations aswell as 21 weeks ultrasound scan were reported nor-mal. Cytogenetic analysis revealed a normal femalekaryotype (46 XX), and no chromosomal abnormali-ties were detected. There was no history of familialimperforate hymen. All serial prenatal ultrasoundscans were performed at a specialist fetal medicineunit. On follow-up scans every 5e10 days, the ap-pearance of the pelvic cystic mass showed a gradualenlargement (Fig 2, panels a, b) and mild bilateral

oof � 09–11–2009 23:14:21

Page 3: Congenital Imperforate Hymen with Hydrocolpos and

UNCORRECTEDPROOF

StAR

CYP11A

CYP17A

CYP19A

ββ-actin

1 2 3

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

Normal

ae

rci

dlo

Fs

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

ae

rc

ni

dl

oF

s

0

1

2

3

4

5

6

7

8

ae

rc

ni

dl

oF

s

0

1

2

3

4

5

6

ae

rc

nidl

oF

s

0

1

2

3

es

ae

rc

ni

dl

oF

Patient

Normal Patient

Normal Patient

Normal Patient

Normal Patient

Fig. 1. Changes in the gene expression of steroidogenic components in the maternal ovary. Lane 1: cDNA from normal ovaries;Lane 2: cDNA from patient; Lane 3: negative control.

Q13Karteris et al: Congenital Imperforate Hymen

ARTICLE IN PRESS

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

389

390

391

392

393

394

395

396

397

398

399

400

401

402

PEDADO1098_proof � 09–11–2009 23:14:21

Page 4: Congenital Imperforate Hymen with Hydrocolpos and

NCORREC

OF

web

4C=F

PO

Fig. 2. Panel a: Longitudinal view of the large cystic ab-dominal mass with gravity dependent echoes, extendingup to the diaphragm at 33� 5 weeks gestation. Panel b:Transverse view at 33� 5 weeks gestation reveals a largecystic abdominal mass. Panel c: Sagittal view of bilateralhydronephrosis, at 33� 5 weeks gestation

web

4C=F

PO

Fig. 3. A view of surgical hymenotomy performed by pedi-atric surgeons.

4 Karteris et al: Congenital Imperforate Hymen

ARTICLE IN PRESS

403

404

405

406

407

408

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

457

458

459

460

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

488

489

490

491

492

493

494

495

496

497

498

499

500

501

502

503

504

505

506

507

508

509

510

511

512

513

514

515

516

517

518

519

520

521

522

523

524

525

526

527

528

529

530

531

532

533

534

535

536

Uhydronephrosis (Fig 2, panel c), but there were nochanges in amniotic fluid volume.

The patient was admitted to the hospital at 32weeks because of premature uterine contractions andcorticosteroids were administered to prepare for even-tual preterm birth as well as tocolytic therapy intrave-nously (IV) to control contractions. At 35 weeks ofgestation the size of cystic mass increased, measuring86� 75 mm maximum and hydronephorsis worsened.

PEDADO1098_pr

TEDPROUreteronephrosis was noticed while amniotic fluid

volume significantly increased (amniotic fluid index(AFI) was 25e27 cm) followed by hydramniosdevelopment. The estimated fetal weight was 3150 g.

Due to premature contractions and a history of pre-vious cesarean section, the patient underwent anemergency cesarean section and a female neonateweighting 3250 g, at 35 weeks of pregnancy, with Ap-gar scores of 8 and 9 after 1 and 5 minutes, respec-tively, was delivered. The neonate was admitted tothe neonatal intensive care unit for ventilatory supportand further investigations. Physical examinationshowed soft but distended mass above the umbilicusabdomen measuring 8� 7 cm.

Bladder catheterization was performed withdifficulty and clear urine was expressed. Renal func-tion tests were normal at birth, with a creatinine of0.7 mmol/L, and urea at 24 mmol/L. Abdominal ultra-sound examination showed a cystic mass posterior tothe bladder, bilateral hydronephrosis (1.3 cm) andhydroureter. MRI revealed an abdominal cystic masswith maximal diameter 90� 70 mm, which was feltto be a hydrometrocolpos due to an imperforatehymen.

Additional investigation of the urinary system dem-onstrated normal kidneys, renal calyces, ureter, anda small bladder displaced to the anterior abdominal walldue to the mass effect of the hydrocolpos. Neither refluxnor ureteroceles were observed. The patient was re-ferred to pediatric surgery. Consent was obtained fromthe baby’s parents, and a hymenectomy was performedwhere approximately 200 mL of clear serous andmucoid fluid was drained (Figs 3 and 4).

Discussion

Congenital imperforate hymen is the most frequentobstructive anomaly of the female genital tract. Thisgenerally occurs sporadically, with a reported

oof � 09–11–2009 23:14:21

Page 5: Congenital Imperforate Hymen with Hydrocolpos and

C

Q3

4web

4C=F

PO

Fig. 4. View of tubing for drainage of retained secretionstrough vagina.

web

4C=F

PO

5Karteris et al: Congenital Imperforate Hymen

ARTICLE IN PRESS

537

538

539

540

541

542

543

544

545

546

547

548

549

550

551

552

553

554

555

556

557

558

559

560

561

562

563

564

565

566

567

568

569

570

571

572

573

574

575

576

577

578

579

580

581

582

583

584

585

586

587

588

589

590

591

592

593

594

595

596

597

598

599

600

601

602

603

604

605

606

607

608

609

610

611

612

613

614

615

616

617

618

619

620

621

622

623

624

625

626

627

628

629

630

631

632

633

634

635

636

637

638

639

640

641

642

643

644

645

Eincidence at term11 of 0.014e1% and gives rise to hy-drometrocolpos in less than 1/16000 female births.12

Failure of this membrane to rupture results in congen-ital imperforate hymen, which in combination withaccumulation of uterovaginal secretions, (producedas a consequence of intrauterine stimulation of cervi-cal mucous glands by maternal estrogen hormones),may lead to the development of an internal hydrome-trocolpos.13 This can be presented as a pelvic mass incombination or not with urinary track obstruction andoligohydramnios.

In this clinical case the cystic mass presented for thefirst time during the 3rd trimester (29 weeks of gesta-tion), having hypoechoic content with a maximumdiameter of 43.5� 29.4 mm. At 35 weeks the cysticmass had a maximum diameter of 86� 75 mm causingbilateral urinary obstruction and hydronephrosis. What

UNCORR

Fig. 5. Diagrammatic representation of steroid hormone biosynthethat have been upregulated in the maternal ovary of the fetus wi

PEDADO1098_proof �

TEDPROOF

is interesting and unique in our case is the fact thatalthough there was a lack of a normal urinary outlet,oligohydramnios was not found. On the contrary, anevident increase of the amniotic fluid volume (AFI,25e27 cm) was observed. Cianciosi et al suggestedthe following mechanisms for accompanied hydram-nios in abdominal cystic masses: (a) the compressionof the adjacent bowel by the expanding cyst causinga hypoperistaltic intestine, or reduction of the absorp-tive capacity of the stomach and bowel by modifyingthe gastrointestinal vascularization, and (b) the depres-sion Qor an incorrect swallowing process, as suggestedby tongue protrusion, reducing the fluid removal fromthe amniotic cavity.14

The differential diagnosis of imperforate hymen isfrom labial adhesions, vaginal atresia, vaginal agene-sis, and transverse vaginal septum. However, the ab-dominal mass has to be diagnosed differentiallyfrom distental urinary bladder, ovarian tumors andneoplasms, mesenteric cysts, anterior meningoceles,reduplication of sigmoid and sacral tumors. Prenatalultrasonographic diagnosis of hydrocolpos has onlybeen reported in three cases,7,15,16 none of whichhad hydramnios detected.

As mentioned previously, it has been hypothesizedthat vaginal secretions accumulate in response tocirculating maternal estrogens.4 Therefore, based onour observations from the gene expression studies, itis attractive to speculate that, in this particular clinicalcase of hydrocolpos, the overall steroidogenic activityin the maternal ovary would have been enhanced. In-deed, when compared to control patients, the largestincrease in gene expression was that of CYP17 andCYP19. CYP17 is expressed in all classic steroido-genic organs and in the human ovary it is selectively

Q5sis steps in the human ovary. In red Q6are the key componentsth hydrocolpos.

646

647

648

649

650

651

652

653

654

655

656

657

658

659

660

661

662

663

664

665

666

667

668

669

670

09–11–2009 23:14:22

Page 6: Congenital Imperforate Hymen with Hydrocolpos and

C

6 Karteris et al: Congenital Imperforate Hymen

ARTICLE IN PRESS

671

672

673

674

675

676

677

678

679

680

681

682

683

684

685

686

687

688

689

690

691

692

693

694

695

696

697

698

699

700

701

702

703

704

705

706

707

708

709

710

711

712

713

714

715

716

717

718

719

720

721

722

723

724

725

726

727

728

729

730

731

732

733

734

735

736

737

738

739

740

741

742

743

744

745

746

747

748

749

750

751

752

753

754

755

756

757

758

759

760

761

762

763

764

765

766

767

768

769

770

771

772

773

774

775

776

777

778

779

780

781

782

783

784

785

786

787

ORRE

expressed in thecal cells.17 CYP19, on the other hand,has a far wider distribution and in the human ovary isprimarily expressed in the corpus luteum. This is ofparticular importance to this case because CYP19catalyzes reactions leading to estrogen biosynthesis.Depending on its expression, CYP19 (P450arom)catalyzes the conversion of the C19 androgens, an-drostenedione and testosterone, to the C18 estrogens,estrone and estradiol, respectively.17

It is well known that steroids such as maternalestrogens as well as progesterone rise exponentiallyduring the later stages in pregnancy. What is interestingin this clinical case is that the control ovarian sampleswere also taken from age-matched women, undergoingcesarean section. As a result, it is the possible dysregu-lation of the maternal steroidogenic pathway in thisclinical case that might contribute to the upregulationof certain enzymes. In addition, with regard to a link be-tween types of circulating estrogens and polyhydram-nios, very little is known. However, a study by Phocaset al showed that there was a discrepancy in the estrogenlevels regarding their increase. This was due to the typepolyhydramnios, the pregnancy outcome, and thecondition of fetus at birth.18

In conclusion, this is a novel clinical case where thereis clear evidence of a maternal steroidogenic over-driveassociated with fetal hydrocolpos, thus potentially link-ing maternal ovarian steroidal stimulation with thispathophysiological condition.

Uncited Figure

Fig 5

References

1. Messina M, Severi FM, Bocchi C, et al: Voluminous perinatalpelvic mass: a case of congenital hydrometrocolpos. J MaternFetal Neonatal Med 2004; 15:135

2. Bakos O, Berglund L: Imperforate hymen and rupturedhematosalpinx: a case report with a review of the literature.J Adolesc Health 1999; 24:226

UNC

PEDADO1098_pr

TEDPROOF

3. Kobayashi H, Yamada Y, Kanayama S, et al: The role ofiron in the pathogenesis of endometriosis. GynecolEndocrinol 2009; 25:39

4. Yıldırım G, Gungorduk K, Aslan H, et al: Prenatal diagno-sis of imperforate hymen with hydrometrocolpos. ArchGynecol Obstet 2008; 278:483

5. Nothnick WB, Zhang X: Future targets in endometriosistreatment: targeting the endometriotic implant. Mini RevMed Chem 2009; 9:324

6. Adaletli I, Ozer H, Kurugoglu S, et al: Congenital imper-forate hymen with hydrocolpos diagnosed using prenatalMRI. AJR Am J Roentgenol 2007; 189:W23

7. Winderl LM, Silverman RK: Prenatal diagnosis of congenitalimperforate hymen. Obstet Gynecol 1995; 85:857

8. Rock JA, Breech LL: Surgery for anomalies of the Muller-ian ducts. In: Rock JA, Jones HW III, editors. Te Linde’sOperative Gynecology, (9th ed.). Philadelphia, LippincottWilliams & Wilkins, 2003, pp 705e749

9. Soloway MS, Rao MK, Kest L: Hematocolpos with urinarytract obstruction in an adult. J Urol 1977; 117:811

10. Kalmantis K, Koumpis C, Daskalakis G, et al: Imperforatehymen with hematocolpometra combined with elevatedCa125. Bratisl Lek Listy 2009; 110:120

11. Mor N, Merlob P, Reisner SH: Types of hymen in the new-born infant. Eur J Obstet Gynecol Reprod Biol 1986; 22:225

12. Benson CB, Doubilet PM: The fetal genitourinary system.In: Fleischer AC, editor. Sonography in Obstetrics and Gy-necology. London, Prentice-Hall International, 1996, pp 444

13. Spence HM: Congenital hydrocolpos. JAMA 1962; 180:1100

14. Cianciosi A, Mancini F, Busacchi P, et al: Increased amnioticfluid volume associated with cloacal and renal anomalies.J Ultrasound Med 2006; 25:1085

15. Davis GH, Wapner RJ, Kurtz AB, et al: Antenatal diagnosis ofhydrometrocolpos by ultrasound examination. J UltrasoundMed 1984; 3:371

16. Hill SJ, Hirsch JH: Sonographic detection of fetal hydro-metrocolpos. J Ultrasound Med 1985; 4:323

17. Payne AH, Hales DB: Overview of steroidogenic enzymesin the pathway from cholesterol to active steroid hormones.Endocr Rev 2004; 25:947

18. Phocas I, Salamalekis E, Sarandakou A, et al: Hormonal andbiochemical parameters in polyhydramnios. Eur J ObstetGynecol Reprod Biol 1987; 25:277

788

789

790

791

792

793

794

795

796

797

798

799

800

801

802

803

804

oof � 09–11–2009 23:14:22